Literature DB >> 17178857

Multiple interacting oncogenes on the 8p11-p12 amplicon in human breast cancer.

Zeng Quan Yang1, Katie L Streicher, Michael E Ray, Judith Abrams, Stephen P Ethier.   

Abstract

The 8p11-p12 genomic region is amplified in 15% of breast cancers and harbors several candidate oncogenes. However, functional evidence for a transforming role for these genes is lacking. We identified 21 genes from this region as potential oncogenes based on statistical association between copy number and expression. We further showed that three of these genes (LSM1, BAG4, and C8orf4) induce transformed phenotypes when overexpressed in MCF-10A cells, and overexpression of these genes in combination influences the growth factor independence phenotype and the ability of the cells to grow under anchorage-independent conditions. Thus, LSM1, BAG4, and C8orf4 are breast cancer oncogenes that can work in combination to influence the transformed phenotype in human mammary epithelial cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17178857     DOI: 10.1158/0008-5472.CAN-06-2946

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  65 in total

1.  A link between smooth muscle cell death and extracellular matrix degradation during vascular atrophy.

Authors:  Richard D Kenagy; Seung-Kee Min; Eileen Mulvihill; Alexander W Clowes
Journal:  J Vasc Surg       Date:  2011-04-14       Impact factor: 4.268

2.  Methylation-associated silencing of SFRP1 with an 8p11-12 amplification inhibits canonical and non-canonical WNT pathways in breast cancers.

Authors:  Zeng-Quan Yang; Gang Liu; Aliccia Bollig-Fischer; Ramsi Haddad; Adi L Tarca; Stephen P Ethier
Journal:  Int J Cancer       Date:  2009-10-01       Impact factor: 7.396

3.  A sparse Ising model with covariates.

Authors:  Jie Cheng; Elizaveta Levina; Pei Wang; Ji Zhu
Journal:  Biometrics       Date:  2014-08-05       Impact factor: 2.571

4.  HDAC2 overexpression correlates with aggressive clinicopathological features and DNA-damage response pathway of breast cancer.

Authors:  Wenqi Shan; Yuanyuan Jiang; Huimei Yu; Qianhui Huang; Lanxin Liu; Xuhui Guo; Lei Li; Qingsheng Mi; Kezhong Zhang; Zengquan Yang
Journal:  Am J Cancer Res       Date:  2017-05-01       Impact factor: 6.166

5.  The HER2 amplicon includes several genes required for the growth and survival of HER2 positive breast cancer cells.

Authors:  Kristine Kleivi Sahlberg; Vesa Hongisto; Henrik Edgren; Rami Mäkelä; Kirsi Hellström; Eldri U Due; Hans Kristian Moen Vollan; Niko Sahlberg; Maija Wolf; Anne-Lise Børresen-Dale; Merja Perälä; Olli Kallioniemi
Journal:  Mol Oncol       Date:  2012-11-24       Impact factor: 6.603

6.  LSM1 over-expression in Saccharomyces cerevisiae depletes U6 snRNA levels.

Authors:  Natalie Luhtala; Roy Parker
Journal:  Nucleic Acids Res       Date:  2009-07-13       Impact factor: 16.971

7.  Relationships linking amplification level to gene over-expression in gliomas.

Authors:  Nicolas Vogt; Anne Gibaud; Anna Almeida; Isabelle Ourliac-Garnier; Michelle Debatisse; Bernard Malfoy
Journal:  PLoS One       Date:  2010-12-08       Impact factor: 3.240

8.  Co-amplified genes at 8p12 and 11q13 in breast tumors cooperate with two major pathways in oncogenesis.

Authors:  S S Kwek; R Roy; H Zhou; J Climent; J A Martinez-Climent; J Fridlyand; D G Albertson
Journal:  Oncogene       Date:  2009-03-30       Impact factor: 9.867

9.  Genomic amplification and oncogenic properties of the GASC1 histone demethylase gene in breast cancer.

Authors:  G Liu; A Bollig-Fischer; B Kreike; M J van de Vijver; J Abrams; S P Ethier; Z-Q Yang
Journal:  Oncogene       Date:  2009-09-28       Impact factor: 9.867

10.  A comprehensive analysis of prognostic signatures reveals the high predictive capacity of the proliferation, immune response and RNA splicing modules in breast cancer.

Authors:  Fabien Reyal; Martin H van Vliet; Nicola J Armstrong; Hugo M Horlings; Karin E de Visser; Marlen Kok; Andrew E Teschendorff; Stella Mook; Laura van 't Veer; Carlos Caldas; Remy J Salmon; Marc J van de Vijver; Lodewyk F A Wessels
Journal:  Breast Cancer Res       Date:  2008-11-13       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.